Drug Information

Drug General Information
Drug ID
D06CXU
Former ID
DIB019274
Drug Name
compound 17
Drug Type
Small molecular drug
Indication Discovery agent Investigative [532342]
Structure
Download
2D MOL
Formula
C18H13Cl2N3O2
InChI
InChI=1S/C18H13Cl2N3O2/c19-13-5-11(6-14(20)8-13)9-22-18-21-4-3-15(23-18)12-1-2-16-17(7-12)25-10-24-16/h1-8H,9-10H2,(H,21,22,23)
InChIKey
FFJGYBJUQCZAAY-UHFFFAOYSA-N
PubChem Compound ID
46926513
PubChem Substance ID
99431972, 124360098, 124950381, 162067044, 163817974, 174512118, 175447766, 249565841
Target and Pathway
Target(s) dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B Target Info Inhibitor [532342]
Cdc2-like kinase 1 Target Info Inhibitor [532342]
CDC-like kinase 2 Target Info Inhibitor [532342]
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A Target Info Inhibitor [532342]
CDC-like kinase 4 Target Info Inhibitor [532342]
NetPath Pathway TCR Signaling Pathway
EGFR1 Signaling Pathway
TGF_beta_Receptor Signaling Pathway
WikiPathways mRNA Processing
References
Ref 532342Small-molecule pyrimidine inhibitors of the cdc2-like (Clk) and dual specificity tyrosine phosphorylation-regulated (Dyrk) kinases: development of chemical probe ML315. Bioorg Med Chem Lett. 2013 Jun15;23(12):3654-61.
Ref 532342Small-molecule pyrimidine inhibitors of the cdc2-like (Clk) and dual specificity tyrosine phosphorylation-regulated (Dyrk) kinases: development of chemical probe ML315. Bioorg Med Chem Lett. 2013 Jun15;23(12):3654-61.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.